Ledger.Open graph →
SEC Form D · Amendment · filed March 27, 2026

NGM Bio Holdings, Inc

Offering
$142.0M
Sold
$142.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Gennadiy Gurevich · BOSTON, MADirectorMikhail Gurevich · BOSTON, MADirectorDiana P. Bockus · South San Francisco, CAExec · DirectorTim P. Kutzkey · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗